SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024994
Filing Date
2021-05-06
Accepted
2021-05-06 16:17:16
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-10q_20210331.htm 10-Q 2261039
2 EX-31.1 mirm-ex311_6.htm EX-31.1 21319
3 EX-31.2 mirm-ex312_9.htm EX-31.2 20860
4 EX-32.1 mirm-ex321_8.htm EX-32.1 9737
5 EX-32.2 mirm-ex322_7.htm EX-32.2 9729
  Complete submission text file 0001564590-21-024994.txt   7700790

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mirm-20210331.xml EX-101.INS 1591939
7 XBRL TAXONOMY EXTENSION SCHEMA mirm-20210331.xsd EX-101.SCH 65294
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mirm-20210331_cal.xml EX-101.CAL 46042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mirm-20210331_def.xml EX-101.DEF 217931
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20210331_lab.xml EX-101.LAB 479383
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20210331_pre.xml EX-101.PRE 355423
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 21898025
SIC: 2834 Pharmaceutical Preparations